BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 208.9 USD | +3.18% |
|
+7.47% | -19.27% |
| Apr. 26 | Guggenheim Adjusts Price Target on Biogen to $255 From $275 | MT |
| Apr. 25 | Biogen Inc. Receives Positive CHMP Opinion for TOFIDence (tocilizumab), a Biosimilar Referencing ROACTEMRA | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 220.75 | 230.07 | 248.12 |
| Spread/Res. | -5.37% | -9.20% | -15.81% |
| Spread/Supp. | +9.65% | +9.65% | +7.47% |
| Support | 190.52 | 190.52 | 194.38 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BIIB Stock
- Charts Biogen Inc.
